Skip to main content

Showing results for Research Updates

Unraveling the Complexities of Cancer Cachexia

The lab of ICMH Member Andrea Bonetto, PhD, investigates the complex and deadly wasting syndrome know as cancer cachexia. Recent breakthroughs have secured external funding via an NIH R01 Grant and opened intriguing lines of inquiry for further study. We sat down with Dr. Bonetto to learn about his work and findings in this often overlooked area of cancer research.

October Research Update

Read the October Research update from Executive Associate Dean Tatiana Foroud, PhD.

Tatiana Foroud, PhD  |  Nov 16, 2021

Single-cell Graph Convolutional Network allows for rapid knowledge transfer

An IU School of Medicine researcher developed a graph artificial intelligence model for single cell omics data analysis. Jing Su, PhD, is one of the corresponding authors of a Nature Communications publication about the single-cell Graph Convolutional Network (scGCN), which can help researchers transfer knowledge across different studies and datasets. scGCN software is currently available for researchers to download and use.

Anna Carrera  |  Nov 09, 2021

New publication means improved outcomes for children with Kawasaki disease

A new publication with contributions from an IU School of Medicine researcher could change the way doctors treat children diagnosed with Kawasaki disease. James Wood, MD, was the local lead investigator and one of the authors of a paper recently published in The Lancet: Child and Adolescent Health, called “Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial.”

Anna Carrera  |  Nov 09, 2021

2021 Showalter Scholars selected

The Showalter Scholar program was instituted to support and recognize faculty who have used their scientific expertise and productivity to make significant contributions to the IU School of Medicine and the field of scientific research.

IU School of Medicine  |  Oct 28, 2021

AstraZeneca's COVID-19 vaccine trial results published in NEJM, IU School of Medicine one of the study sites

Pharmaceutical giant, AstraZeneca, has published its COVID-19 vaccine data in the highly credible scientific journal, New England Journal of Medicine. Results published in the journal show that the vaccine known as AZD1222 is a safe and effective way to prevent people from getting symptomatic cases of COVID-19. More than 32,000 adults participated in the study, and more than 500 of them were from Indiana, as IU School of Medicine was one of more than 80 sites conducting a portion of this important study.

Christine Drury  |  Oct 05, 2021

IU researchers study long-term effects of COVID-19 on bone growth

SARS-CoV-2 can cause quick and significant bone loss—even when infections of the virus that causes COVID-19 appear to be mild.

Researchers in the Department of Orthopaedic Surgery at Indiana University School of Medicine discovered that mouse models infected with the novel coronavirus lost approximately 25% of their bone mass within two weeks of contagion. They also found mouse models with a 63% increase in osteoclasts, the cells that cause bone to break down.

Caitlin VanOverberghe  |  Oct 04, 2021

August Research Update

Read the August Research update from Executive Associate Dean Tatiana Foroud, PhD.

Tatiana Foroud, PhD  |  Aug 31, 2021

Study: Minimally-invasive surgery for hip gunshot wounds can be risky

Orthopaedic surgeons hoping to use a common, minimally-invasive procedure to treat gunshot wounds to the hip must be aware that such surgeries come with a very high risk of complications, according to clinical research conducted by Indiana University School of Medicine faculty.

Caitlin VanOverberghe  |  Aug 30, 2021